This article describes a recently finalized CMS rule addressing the permissibility of co-pay accumulator adjustment programs (CAAPs) when no generic is available.
Bryan S. Walsh, JD
Advertisement
Articles by Bryan S. Walsh, JD
Advertisement
Latest Updated Articles
- CAAP Rule and Prescription Drug Prices
March 18th 2021
Advertisement
Advertisement
Trending on AJMC
1
Trump Childhood Vaccine Order: What It Means for Parents and Payers
2
Senate Unveils Sweeping Bill to Reform 340B Drug Program
3
Occupational Triggers Fuel Half of CHE Cases, Spanish Study Finds
4
Access, Coverage, and Final Reflections on Managing Alzheimer's Disease Agitation
5